An immunocompetent transplantable mouse model of basal cell carcinoma

This publication has 36 references indexed in Scilit:

• Epigenomic regulation of stemness contributes to the low immunogenicity of the most mutated human cancer
  Cell Reports, 2025
• European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma—update 2023
  European Journal of Cancer, 2023
• Immunotherapy for keratinocyte cancers. Part I: Immune-related epidemiology, risk factors, pathogenesis, and immunotherapy management of keratinocyte cancers
  Journal of the American Academy of Dermatology, 2023
• Cemiplimab in locally advanced basal cell carcinoma after hedgehog inhibitor therapy: an open-label, multi-centre, single-arm, phase 2 trial
  The Lancet Oncology, 2021
• The site of tumor development determines immunogenicity via temporal mobilization of antigen‐laden dendritic cells in draining lymph nodes
  European Journal of Immunology, 2015
• Establishment of Murine Basal Cell Carcinoma Allografts: A Potential Model for Preclinical Drug Testing and for Molecular Analysis
  Journal of Investigative Dermatology, 2011
• Basal Cell Carcinomas Arise from Hair Follicle Stem Cells in Ptch1+/− Mice
  Cancer Cell, 2011
• K15 Expression Implies Lateral Differentiation within Stratified Epithelial Basal Cells
  Laboratory Investigation, 2000
• Basal cell carcinomas in mice overexpressing Gli2 in skin
  Nature Genetics, 2000
• Activating Smoothened mutations in sporadic basal-cell carcinoma
  Nature, 1998